Colorectal cancer (CRC) is a predominant life‐threatening cancer, with liver and peritoneal
metastases as the primary causes of death. Intestinal inflammation, a known CRC risk factor …

Colorectal cancer (CRC) is a common malignancy worldwide. In CRC patients, metastases
are the main cause of cancer-related mortality. In a group of metastatic CRC patients, the …

Purpose To evaluate the feasibility and efficacy of stereotactic body radiation therapy
(SBRT) in the treatment of colorectal liver metastases. Methods Forty-two patients with …

Objective: To assess factors affecting long-term survival of patients undergoing
radiofrequency ablation (RFA) of colorectal hepatic metastases, with attention to evolving …

This multicenter phase I/II study evaluated the safety, pharmacokinetics, and antitumor
effects of repeated doses of NV1020, a genetically engineered oncolytic herpes simplex …

Surgical resection is the only option of cure for patients with metastatic colorectal cancer
(CRC). However, the risk of recurrence within 18 mo after metastasectomy is around 75 …

Colorectal cancer (CRC) is the third most common malignancy and the second most
common cause of cancer-related mortality worldwide. A total of 20% of CRC patients present …

Purpose Metastatic disease is a major cause of mortality in colorectal cancer patients. Even
after complete resection of isolated liver metastases, recurrence develops in the majority of …

Abstract Background The Immunoscore was initially established to evaluate the prognosis of
stage I/II/III colorectal cancer patients. However, the feasibility of the Immunoscore for the …

Colorectal cancer is the third most commonly diagnosed cancer in the United States. While
screening methods strive to improve rates of early stage detection, 25% of patients have …